For the first half of FY27, Aavas Financiers reported assets under management (AUM) of ₹24,800 crore, up 16.1% year-on-year.

Sumitomo Chemical India reported a 12.4% YoY decline in Q2 net profit to ₹156 crore, while revenue fell 2.5% to ₹891 crore. EBITDA declined 15.7% to ₹183 crore, and the EBITDA margin narrowed to 20.56 ...

The IPO is expected to establish Anthropic as a benchmark for how Wall Street values leading AI companies, including rival ...

Benchmark equity indices rebounded by around 0.7% on Monday, with Sensex and Nifty recovering after a four-day decline, ...

If allotted one lot, the investor’s holding would be worth approximately ₹16,428 at the implied listing price, translating into an estimated gain of ₹3,000. For an investor allotted five lots, the ...

Tata Consumer Products, Bank of Maharashtra, Aequs, Dalmia Bharat, Mankind Pharma, REC and Sona BLW shares in focus after Q2 ...

Mankind Pharma’s operating margin widened to 27% from 24.9% a year earlier. Its board also approved plans to merge two wholly owned subsidiaries into the company.

E2E Networks said the proposed capacity addition would help it cater to the demand for GPUs and related services. The rollout will be guided by its infrastructure deployment plan and anticipated ...

Peter Kenyon, who formerly led Manchester United and Chelsea, said feedback in sports is constant and immediate.

The tech-heavy US index Nasdaq Composite is down 6 per cent since October 6, with Meta and NVIDIA falling 12-13 per cent and ...

The Paras Healthcare IPO allotment status is expected to be finalized on October 26, with listing on October 28. Check your ...

Apollo Micro Systems is also building capabilities in explosives and energetics through the IDL and the Premier Explosives ...